Brief: Masonic Cancer Center, University Of Minnesota To Present Phase 1 Clinical Trial Data For Hcw9218 In Solid Tumors
08/11/2022 12:46
Nov 8 (Reuters) - HCW Biologics Inc HCWB.O :
* MASONIC CANCER CENTER, UNIVERSITY OF MINNESOTA TO PRESENT
DATA
IN POSTER PRESENTATION FROM THE PHASE 1 CLINICAL TRIAL TO
EVALUATE HCW9218 IN SOLID TUMORS AT THE SITC 37TH ANNUAL MEETING
Source text for Eikon: ID:nGNX35t9Cw
Further company coverage: HCWB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Hcw Biologics
See all newsBrief: Hcw Biologics Maintains Momentum Toward Completion Of Ind Application For Clinical Study To Evaluate Lead T-Cell Engager In Solid Tumors
Brief: HCW Biologics Registers Resale Of Up To 1.81 Mln Shares Of Common Stock By Selling Stockholder- SEC Filing
NASDAQ RESUMED AT 10:34 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:29 AM
NASDAQ RESUMED AT 10:29 AM